Wegener’s granulomatosis and pyoderma gangrenosum – rare causes of facial ulcerations
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue
Abstract
Background: Pyoderma gangrenosum (PG) is caused by immune system dysfunction, and particularly improper functioning of neutrophils. At least half of all PG patients also suffer from autoimmunological diseases, one of which is Wegener granulomatosis (WG). The purpose of this article was to compare cases of patients with WG and PG in terms of their clinical course, histopathology, and applied treatment. In both, histopathological features are not fully distinct. Data from microbiological and immunological evaluation and clinical presentation are required to establish the diagnosis. We also present the case of a patient with WG and deep facial skin lesions not responding to standard treatment.Methods: Systematic review of the literature in PubMed using the search terms “Wegener granulomatosis AND Pyoderma gangrenosum” and case report.Results: The finding of 22 reports in the literature (PubMed) suggests that it is a rare phenomenon. This study revealed a similar rate of comorbidity of WG and PG in both genders and an increased incidence of both diseases after the age of 50. Among skin lesions there was a dominance of ulceration, most often deep and painful, covering a large area with the presence of advanced necrosis and destruction of the surrounding tissue. The most common location proved to be the cervical-cephalic area. The most popular treatment included steroids with cyclophosphamide.Discussion: The rarity of the coexistence of these two diseases results in a lack of effective therapy. In such cases sulfone derivatives are still effective and provide an alternative to standard immunosuppression methods. Hyperbaric therapy and plasmapheresis can also play an important complementary role.
Authors and Affiliations
Karolina Kędzierska, Krzysztof Sindrewicz, Tomasz Smektała, Magda Wiśniewska, Marek Masiuk, Ewelina Staniszewska, Katarzyna Sporniak- Tutak, Edyta Gołembiewska, Kazimierz Ciechanowski
Keywords
Related Articles
- EP ID EP220677
- DOI -
- Views 126
- Downloads 0
New cytochrome P450 isoforms as cancer biomarkers and targets for chemopreventive and chemotherapeutic agents
Cytochromes P450 (P450) are a multigene family of enzymes possessing a central role in the oxidative metabolism of a wide range of xenobiotics, including anticancer drugs, and endogenous compounds. The activity of differ...
Anti‑cytokine therapy for psoriasis – not only TNF‑α blockers. Overview of reports on the effectiveness of therapy with IL‑12/IL‑23 and T and B lymphocyte inhibitors
TNF‑α inhibitors – infliximab, etanercept and adalimumab – can be used in the treatment of psoriasis vulgaris and psoriatic arthritis, along with other inhibitors of proinflammatory cytokines, such as interleukin‑12 (IL‑...
Assessment of cytotoxic potential of root canal sealers after hardening – an ex vivo study
The aim of this study was to perform a comparative assessment of the toxic action of root canal sealers currently on the market on human gingival fibroblasts after setting.The inserts with an equal quantity of set root c...
Angiogeneza i immunosupresja: jin i jang progresji nowotworów?
Podczas progresji nowotworowej powstają swoiste warianty komórek nowotworowych, które mają zdolność rekrutowania ze szpiku i z krwiobiegu niektórych komórek hematopoetycznych i mezenchymalnych. Wśród rekrutowanych komóre...
Kinaza białkowa aktywowana przez AMP (AMPK) jako cel terapeutyczny
Kinaza białkowa aktywowana przez AMP (AMPK) jest głównym czujnikiem stanu metabolicznego, działającym zarówno na poziomie komórkowym jak i całego organizmu. Enzym ten jest heterotrimerem składającym się z trzech podjedno...